This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Drug-eluting stents (DESs) have become the gold standard of coronary angioplasty since their inception in 2002. vs 57.5%, p=0.010), a greater average number of stents implanted per patient (1.72±0.92 vs 57.5%, p=0.010), a greater average number of stents implanted per patient (1.72±0.92
Stone, MD Mount Sinai Health System tim.hodson Wed, 04/02/2025 - 15:26 March 31, 2025 Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is safer and more effective for patients with severely calcified coronary artery disease than conventional angiography, the more commonly used technique.
Occlusion myocardialinfarction is a clinical diagnosis Written by Willy Frick (@Willyhfrick). Here is the angiogram after stent placement. The patient suffered a large infarct. St depression in lead AVL differentiates inferior st-elevation myocardialinfarction from pericarditis. Circulation , 130 (25).
Objectives There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardialinfarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods.
Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Uncertainty was explored by probabilistic bootstrapping.
(MedPage Today) -- For the first time, intravascular imaging-guided coronary stenting was associated with better survival and reduced myocardialinfarction (MI) in a meta-analysis powered to detect these benefits against angiography, researchers.
The patient presented to an outside hospital An 80yo female per triage “patient presents with chest pain, also hurts to breathe” PMH: CAD, s/p stent placement, CHF, atrial fibrillation, pacemaker (placed 1 month earlier), LBBB. Smith: This is an enormous myocardialinfarction. This was stented with a 2.25 Next trop in AM.
suggest that the drug-coated balloon offers an effective treatment strategy for the management of coronary in-stent restenosis, or blockages recurring within previously placed stents. In particular, patients with multiple prior stents have very poor long-term outcomes.
(MedPage Today) -- As a stricter gatekeeper to nonculprit lesion intervention in people with acute myocardialinfarction (MI) going for complete revascularization, fractional flow reserve (FFR) guidance was projected to save medical costs and increase.
Among the patients included, those with diabetes exhibited higher rates of adverse events, including death, spontaneous myocardialinfarction (MI), and repeat revascularization. Pooled data from four trials were analyzed, encompassing patients undergoing PCI or CABG for left main disease.
The 2 coprimary outcomes were target lesion revascularization and myocardialinfarction. The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardialinfarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events.
BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013006, January 1, 2024. mm2for distal LM (area under the curve, 0.57;P=0.15),
He underwent coronary stenting (uncertain which artery). He underwent immediate CPR, was found to be in ventricular fibrillation, and was successfully resuscitated. I do not have the post-resuscitation ECG. He underwent months of rehabilitation and was able to return to work part time. Could this have been avoided?
ConclusionsARBBB is a predictor of inhospital SCD, CR, and 2year major adverse cardiovascular and cerebrovascular events in patients with firstepisode acute myocardialinfarction undergoing percutaneous coronary intervention with a drugeluting stent.
Clinical success was defined as optimal stent expansion after final treatment with no in-hospital major adverse cardiovascular event (MACE). stent expansion at Maximum Calcium Site 96.7% stent expansion at Maximum Calcium Site 96.7% Clinical Safety and Effectiveness Results: - 98.3%
Patients with ST-segment–elevation myocardialinfarction undergoing primary percutaneous coronary intervention were randomly assigned by center to receive low-dose PPA or matching placebo for at least 48 hours. Circulation, Ahead of Print. mg·kg·h of bivalirudin intravenously). mg·kg·h of bivalirudin intravenously).
BACKGROUND:Current therapy for in-stent restenosis (ISR) is based on drug-eluting stents (DES) or drug-eluting balloon catheters. mm), except in the post hoc subanalysis for the BMS-ISR group (0.203 mm [95% CI, 0.584 to 0.178]).
Background Bioresorbable vascular scaffolds (BVS) were designed to reduce the rate of late adverse events observed in conventional drug-eluting stents (DES) by dissolving once they have restored lasting patency.
Background For high bleeding-risk patients (HBR) undergoing percutaneous coronary intervention (PCI), the LEADERS FREE (LF) and LEADERS FREE II (LF II) trials established the safety and efficacy of a stainless steel polymer-free biolimus-coated stent (SS-BCS) with 30 days of dual antiplatelet treatment (DAPT).
The purpose of this report is to use propensity score matching to determine gender-specific differences in clinical outcomes after percutaneous coronary interventions with polymer-free sirolimus-coated stents.
vs 13.6%), any stent thrombosis (RR=1.42; 95% CI [0.35, 5.72]; p=0.62; 2.2% vs 13.6%), any stent thrombosis (RR=1.42; 95% CI [0.35, 5.72]; p=0.62; 2.2% However, FFR-guided CR showed no beneficial effect on all-cause mortality, stroke, major bleeding and myocardialinfarction.
Drug‐eluting stents have been shown to be superior to bare‐metal stents in patients with HBR, even when patients were given abbreviated periods of dual antiplatelet therapy (DAPT). Short DAPT has not been evaluated with the EluNIR ridaforolimus‐eluting stent. presented with acute coronary syndrome; 33.7%
Background:Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (ACS). Circulation, Ahead of Print. 0.80];P<0.001 for noninferiority;P=0.002 for superiority). versus 3.4%; HR, 0.35 [95% CI, 0.20–0.61];P<0.001).Conclusions:This
BackgroundP2Y12inhibitorbased single antiplatelet therapy (SAPT) after drugeluting stent implantation reduces major bleeding without increasing the risk of major adverse cardiovascular and cerebral events compared with 12month dual antiplatelet therapy (DAPT). Journal of the American Heart Association, Ahead of Print.
BACKGROUNDCarotid artery stenting (CAS) has emerged as a viable alternative to carotid endarterectomy for managing carotid artery stenosis in high‐risk patients. Outcomes of interest were stroke, transient ischemic attack, death, myocardialinfarction, and access site complications. 1.96]; I2= 0%). 1.98]; I2= 0%).CONCLUSIONNo
of the patients were diagnosed with non-ST elevated myocardialinfarction (NSTEMI), 36.8% with ST elevated myocardialinfarction (STEMI), 3.41% with unstable angina, 0.56% with stable angina, and 0.11% were diagnosed with various types of arrhythmias. Approximately 48.5% and 1.3%, respectively.
So this is indeed diagnostic of myocardialinfarction. Not immediately, at least, because this is NOT diagnostic of ACUTE (occlusion) myocardialinfarction (Acute OMI). So I made an ED diagnosis of Non-Occlusion MyocardialInfarction (NOMI), and his next day angiogram confirmed NOMI.
Publication date: Available online 4 March 2024 Source: The American Journal of Cardiology Author(s): Sanjit S. Jolly, Shun Fu Lee, Rajibul Mian, Sasko Kedev, Shahar Lavi, Raul Moreno, Gilles Montalescot, Ali Hillani, Timothy D. Henry, Valon Asani, Robert F. Storey, Johanne Silvain, James C.S.
Background Untreated multivessel disease (MVD) in acute myocardialinfarction (AMI) has been linked to a higher risk of recurrent ischemia and death within one year. Similarly, all-cause mortality, cardiovascular mortality, stent thrombosis, and acute renal insufficiency did not show significant differences between two groups.
So we know there is myocardialinfarction and the patient has persistent pain, but it is very mild. The culprit was opened and stented. Only the ECG and presence or absence of pain can tell you what is happening right now. Again , I would give NTG and re-assess. Case continued: A 2nd troponin I returned at 744 ng/L.
Doctors then treat the cause of the heart attack, either inserting a stent, removing a clot or taking other necessary action. The Impella® heart pump, an FDA-approved device, is inserted through a catheter in the groin as soon as the patient arrives at the hospital. Division Head of Cardiology at Henry Ford Health.
If the FFR normalizes after stenting, the restenosis rates at six months is less than 5%. Since the FFR wire can be used for guiding balloon catheters and stents, it is easy to make post procedure measurements without any additional effort. Routine FFR measurement probably lead to more judicious use of stents and improved outcomes.
She was taken to the cath lab, where she was found to have 100% in-stent restenosis of the proximal LAD. Hyperacute T Wave in the Early Diagnosis of Acute MyocardialInfarction. Interpretation of acute myocardialinfarction with persistent “hyperacute T waves” by cardiac magnetic resonance. 2023;82:194–202.
3.30]) and subacute definite or probable stent thrombosis (0.58% and 0.17%; hazard ratio, 3.40 [95% CI, 1.26–9.23]) years; men, 76.6%; acute coronary syndrome, 75.0%). There was no difference in net adverse clinical outcomes and each component of coprimary cardiovascular end point.
A comparison of electrocardiographic changes during reperfusion of acute myocardialinfarction by thrombolysis or percutaneous transluminal coronary angioplasty. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardialinfarction. Am Heart J. 2000;139:430–436. Am J Cardiol.
Angiogram reportedly showed acute thrombotic occlusion of the first obtuse marginal which was stented. V5-V6) of any amplitude, is specific for Occlusion MyocardialInfarction (vs. Only when the first troponin (high sens trop I) returned at around 22,000 ng/L did the cardiologist reconsider. Peak troponin was not recorded.
Previous medical interventions included a spectrum of procedures, including catheter-directed thrombectomy for popliteal artery aneurysms with thrombosis, vascular bypass grafting for cerebral-anterior communicating artery aneurysms and arch replacement and stent implantation for aortic dissecting aneurysms.
Patients with diabetes experienced higher rates of 5-year death (158/1104 [Kaplan-Meier rate, 14.7%] versus 297/3289 [9.3%];P<0.001), spontaneous myocardialinfarction (MI; 67/1104 [6.7%] versus 114/3289 [3.7%];P<0.001), and repeat revascularization (189/1104 [18.5%] versus 410/3289 [13.2%];P<0.001).
Objective:To compare the 1-month stroke, myocardialinfarction (MI), and/or death rates among symptomatic patients undergoing either CAS or CEA according to the timing of the procedure in Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).Methods:We
Anaphylaxis leads to plaque rupture or erosion leading to acute myocardialinfarction (type II) and acute coronary stent thrombosis (type III). Here we share a case of Kounis syndrome type I caused by an allergy caused by a Cryptopteran bite.
Methods and analysis The SPECTRUM study is a prospective investigator-initiated single-centre single-arm observational cohort study aiming to enrol 200 patients presenting with ST-segment elevation myocardialinfarct undergoing IVUS-guided primary PCI.
Background:Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are two types of carotid revascularization procedures performed on symptomatic patients. Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. This data provides further insight into the risks involved in carotid revascularization procedures.
The near-immediate or instant feedback learning process by which the heart responds to any new invasive procedural variation facilitates each new change; be it drug-eluting stent, drug-coated balloon, or both in different combinations and permutations.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content